1. The European Agency for the evaluation of medicinal products: Position paper on terminology in pharmacogenetics. Available from:; 2002.
2. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe workshop;Lesko;J Clin PHarmacol,2003
3. US Department Health and Human Services Food and Drug Administration. Guidance for industry: pharmacogenomics data submissions. Available from:; 2005.
4. General principles: processing joint FDA EMEA voluntary genomic data submissions (VGDSs) within the framework of the confidentiality arrangement. Available from:; 2006.
5. US Department Health and Human Services Food and Drug Administration. Guidance for industry: E15 definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories. Available from:; 2008.